ATE383159T1 - Nicht-sedierende barbituratverbindungen als neuroprotektive wirkstoffe - Google Patents
Nicht-sedierende barbituratverbindungen als neuroprotektive wirkstoffeInfo
- Publication number
- ATE383159T1 ATE383159T1 AT01959195T AT01959195T ATE383159T1 AT E383159 T1 ATE383159 T1 AT E383159T1 AT 01959195 T AT01959195 T AT 01959195T AT 01959195 T AT01959195 T AT 01959195T AT E383159 T1 ATE383159 T1 AT E383159T1
- Authority
- AT
- Austria
- Prior art keywords
- neuroprotective agents
- sedative
- sedating barbiturate
- barbiturate compounds
- compounds
- Prior art date
Links
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical class O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004090 neuroprotective agent Substances 0.000 title 1
- 239000000932 sedative agent Substances 0.000 abstract 3
- 230000001624 sedative effect Effects 0.000 abstract 3
- 229940125717 barbiturate Drugs 0.000 abstract 2
- 230000004112 neuroprotection Effects 0.000 abstract 2
- IKVPZYAOGOJTLK-UHFFFAOYSA-N 5,5-diphenyl-1,3-diazinane-2,4,6-trione Chemical compound O=C1NC(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 IKVPZYAOGOJTLK-UHFFFAOYSA-N 0.000 abstract 1
- 206010002091 Anaesthesia Diseases 0.000 abstract 1
- 230000037005 anaesthesia Effects 0.000 abstract 1
- -1 barbiturate compound Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22167200P | 2000-07-26 | 2000-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE383159T1 true ATE383159T1 (de) | 2008-01-15 |
Family
ID=22828824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01959195T ATE383159T1 (de) | 2000-07-26 | 2001-07-26 | Nicht-sedierende barbituratverbindungen als neuroprotektive wirkstoffe |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1311270B1 (https=) |
| JP (1) | JP5047442B2 (https=) |
| CN (2) | CN100522172C (https=) |
| AT (1) | ATE383159T1 (https=) |
| AU (2) | AU8077801A (https=) |
| BR (1) | BR0112775A (https=) |
| CA (1) | CA2416535C (https=) |
| DE (1) | DE60132337T2 (https=) |
| ES (1) | ES2300349T3 (https=) |
| IL (3) | IL154060A0 (https=) |
| MX (1) | MXPA03000824A (https=) |
| PT (1) | PT1311270E (https=) |
| WO (1) | WO2002007729A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093820A (en) | 1997-10-02 | 2000-07-25 | Taro Pharmaceutical Industries Ltd. | Method and reagents for N-alkylating ureides |
| WO2002007729A1 (en) * | 2000-07-26 | 2002-01-31 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
| US6939873B2 (en) | 2000-07-26 | 2005-09-06 | Taro Pharmaceuticals Industries Limited | Non-sedating barbituric acid derivatives |
| US7683071B2 (en) | 2000-07-26 | 2010-03-23 | Taro Pharmaceuticals Industries Ltd. | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
| US6756379B2 (en) | 2001-07-26 | 2004-06-29 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
| EP1485101A4 (en) * | 2002-01-30 | 2006-04-12 | Taro Pharma Ind | NON-SURFACTANT BARBITIC ACID DERIVATIVES |
| BR0314617A (pt) | 2002-10-11 | 2005-08-02 | Baxter Int | Método para cardioproteção e neuroproteção por administração intravenosa de anestésico voláteis halogenados |
| WO2004052350A2 (en) * | 2002-12-11 | 2004-06-24 | Taro Pharmaceutical Industries Limited | Method of treating movement disorders using barbituric acid derivatives |
| EP1625848A1 (en) * | 2004-08-10 | 2006-02-15 | Taro Pharmaceuticals North America, Inc. | Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid |
| RU2370266C2 (ru) * | 2007-12-21 | 2009-10-20 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ общего обезболивания |
| WO2013038427A1 (en) * | 2011-09-12 | 2013-03-21 | Council Of Scientific & Industrial Research | ARYLATED β-DICARBOIMYL COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF |
| CN102863579B (zh) * | 2012-09-14 | 2014-02-05 | 东南大学 | 一种巴比妥酸螯合树脂及其制备方法和应用 |
| EP3329279B1 (en) | 2015-10-05 | 2021-07-07 | The University of North Carolina at Chapel Hill | Decoding methods for multiplexing assays and associated fluidic devices, kits, and solid supports |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69722A (en) * | 1983-09-14 | 1986-09-30 | Taro Pharma Ind | Oxopyrimidine derivatives and pharmaceutical compositions containing them |
| US4833148A (en) * | 1987-04-09 | 1989-05-23 | Washington University | Method of using alkenyl- or alkynyl-substituted thiobarbiturates to reduce neurotoxic injury |
| US5474990A (en) * | 1989-10-20 | 1995-12-12 | Olney; John W. | Barbiturates as safening agents in conjunction with NMDA antagonists |
| WO2002007729A1 (en) * | 2000-07-26 | 2002-01-31 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
-
2001
- 2001-07-26 WO PCT/US2001/023420 patent/WO2002007729A1/en not_active Ceased
- 2001-07-26 AT AT01959195T patent/ATE383159T1/de not_active IP Right Cessation
- 2001-07-26 CN CNB2006100813267A patent/CN100522172C/zh not_active Expired - Fee Related
- 2001-07-26 AU AU8077801A patent/AU8077801A/xx active Pending
- 2001-07-26 MX MXPA03000824A patent/MXPA03000824A/es active IP Right Grant
- 2001-07-26 CN CNB018151426A patent/CN1329032C/zh not_active Expired - Fee Related
- 2001-07-26 DE DE60132337T patent/DE60132337T2/de not_active Expired - Lifetime
- 2001-07-26 JP JP2002513464A patent/JP5047442B2/ja not_active Expired - Fee Related
- 2001-07-26 AU AU2001280778A patent/AU2001280778B2/en not_active Ceased
- 2001-07-26 ES ES01959195T patent/ES2300349T3/es not_active Expired - Lifetime
- 2001-07-26 PT PT01959195T patent/PT1311270E/pt unknown
- 2001-07-26 BR BR0112775-6A patent/BR0112775A/pt not_active Application Discontinuation
- 2001-07-26 IL IL15406001A patent/IL154060A0/xx unknown
- 2001-07-26 EP EP01959195A patent/EP1311270B1/en not_active Expired - Lifetime
- 2001-07-26 CA CA2416535A patent/CA2416535C/en not_active Expired - Fee Related
-
2003
- 2003-01-20 IL IL154060A patent/IL154060A/en not_active IP Right Cessation
-
2004
- 2004-11-03 IL IL16501704A patent/IL165017A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002007729A9 (en) | 2002-08-08 |
| ES2300349T3 (es) | 2008-06-16 |
| BR0112775A (pt) | 2003-12-30 |
| AU8077801A (en) | 2002-02-05 |
| JP2004517808A (ja) | 2004-06-17 |
| EP1311270A4 (en) | 2006-04-12 |
| PT1311270E (pt) | 2008-04-15 |
| EP1311270A1 (en) | 2003-05-21 |
| CA2416535A1 (en) | 2002-01-31 |
| EP1311270B1 (en) | 2008-01-09 |
| DE60132337T2 (de) | 2009-02-12 |
| CN1461219A (zh) | 2003-12-10 |
| MXPA03000824A (es) | 2004-11-01 |
| CA2416535C (en) | 2010-11-16 |
| DE60132337D1 (de) | 2008-02-21 |
| CN100522172C (zh) | 2009-08-05 |
| CN1872067A (zh) | 2006-12-06 |
| IL165017A0 (en) | 2005-12-18 |
| IL154060A (en) | 2013-05-30 |
| WO2002007729A1 (en) | 2002-01-31 |
| AU2001280778B2 (en) | 2004-09-02 |
| JP5047442B2 (ja) | 2012-10-10 |
| IL154060A0 (en) | 2003-07-31 |
| HK1100814A1 (en) | 2007-09-28 |
| CN1329032C (zh) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE383159T1 (de) | Nicht-sedierende barbituratverbindungen als neuroprotektive wirkstoffe | |
| DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
| AU7315301A (en) | Compounds and compositions for delivering active agents | |
| BRPI0411241A (pt) | agentes terapêuticos úteis para o tratamento de dor | |
| CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
| PL378238A1 (pl) | Związki biaromatyczne, które aktywują receptory typu PPAR<$Egamma>, oraz ich zastosowanie w kompozycjach kosmetycznych albo farmaceutycznych | |
| BR9812492A (pt) | Composto, uso do mesmo, formulação farmacêutica, e, processos para o tratamento de uma doença cardiovascular, para o tratamento de uma vasoconstrição, e para a preparação de compostos | |
| DE60138709D1 (de) | Analoge der barbitursäure als therapeutische wirkstoffe | |
| DE69637050D1 (de) | Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer | |
| DE60024414D1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
| IL162614A (en) | Alpha tocopherol esters for use in treating culture-borne cell disease by aerosol administration | |
| DE60022895D1 (de) | Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| NZ509172A (en) | Antimalarial agents | |
| AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| EA199800013A1 (ru) | Способы минимизации остеопороза | |
| ES2091126T3 (es) | Nuevos compuestos biciclicos de pirimidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
| BRPI9916820A2 (pt) | Formulações farmacêuticas | |
| BR0111669A (pt) | Novos compostos | |
| ES2105923B1 (es) | Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv). | |
| ATE173926T1 (de) | Arzneizusammensetzungen enthaltend tandospiron oder seine analoge | |
| FR2767526B1 (fr) | Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant | |
| MY153713A (en) | A pharmaceutical composition comprising 3, 4-dihydro-3-methyl-4-oxoimidazo [5,1-d]-1,2,3,5-tetrazine-8-carboxylate | |
| EP1905441A3 (en) | Non-sedating barbiturate compounds as neuroprotective agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |